Hosted by ACER, sponsored by Senzime
Jun 10, 2025 05:00 PM Eastern US Time
Join a panel of esteemed subject matter experts as they explore the clinical challenge of residual neuromuscular block (rNMB) and residual paralysis in patients undergoing surgery.
Despite advancements in anesthesia, residual paralysis continues to pose significant risks, including postoperative respiratory complications and increased post anesthesia care unit (PACU) length of stay (LoS). Studies show that PACU LoS can increase with average delays of 80 minutes, leading to higher hospital costs and ICU admissions (Carvalho et al., 2020; Butterly et al., 2010; Grabitz et al., 2019).
This discussion will highlight key clinical data and emphasize the importance of quantitative train-of-four (TOF) monitoring, a critical element in Enhanced Recovery After Surgery (ERAS) protocols. Learn how an electromyography (EMG)-based quantitative TOF monitor like the next-generation TetraGraph® supports improved dosing, effective reversal of muscle relaxants, and safe extubation—leading to enhanced patient safety and better recovery outcomes.